Tivity Health, Inc. (NASDAQ:TVTY) Expected to Announce Quarterly Sales of $135.00 Million

Wall Street analysts expect Tivity Health, Inc. (NASDAQ:TVTYGet Rating) to report sales of $135.00 million for the current quarter, according to Zacks Investment Research. Four analysts have made estimates for Tivity Health’s earnings, with the lowest sales estimate coming in at $132.80 million and the highest estimate coming in at $139.10 million. Tivity Health reported sales of $120.07 million during the same quarter last year, which indicates a positive year-over-year growth rate of 12.4%. The business is expected to report its next quarterly earnings report on Monday, January 1st.

On average, analysts expect that Tivity Health will report full year sales of $552.25 million for the current fiscal year, with estimates ranging from $541.19 million to $565.73 million. For the next fiscal year, analysts forecast that the business will report sales of $613.20 million, with estimates ranging from $596.01 million to $636.27 million. Zacks’ sales calculations are an average based on a survey of sell-side research analysts that cover Tivity Health.

Tivity Health (NASDAQ:TVTYGet Rating) last issued its quarterly earnings results on Thursday, May 5th. The company reported $0.40 EPS for the quarter, missing the consensus estimate of $0.42 by ($0.02). Tivity Health had a net margin of 17.25% and a return on equity of 75.94%. The business had revenue of $127.51 million during the quarter, compared to analysts’ expectations of $132.21 million. During the same period in the prior year, the business earned $0.40 EPS. The business’s quarterly revenue was up 18.0% on a year-over-year basis.

Several brokerages recently issued reports on TVTY. Barrington Research downgraded shares of Tivity Health from an “outperform” rating to a “market perform” rating in a research note on Tuesday, April 5th. Zacks Investment Research raised shares of Tivity Health from a “sell” rating to a “hold” rating in a report on Wednesday, May 25th. William Blair reiterated a “market perform” rating on shares of Tivity Health in a research note on Thursday, February 24th. Credit Suisse Group increased their price objective on shares of Tivity Health from $29.00 to $31.00 and gave the company a “neutral” rating in a research note on Friday, March 11th. Finally, StockNews.com started coverage on shares of Tivity Health in a research note on Thursday, March 31st. They set a “hold” rating on the stock. Seven analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $30.67.

TVTY stock opened at $32.34 on Friday. The company has a market cap of $1.61 billion, a P/E ratio of 18.91, a P/E/G ratio of 1.81 and a beta of 2.14. Tivity Health has a 52 week low of $21.25 and a 52 week high of $32.89. The company’s 50-day moving average price is $32.07 and its 200 day moving average price is $28.30. The company has a current ratio of 2.47, a quick ratio of 2.47 and a debt-to-equity ratio of 2.97.

Several institutional investors have recently bought and sold shares of the company. Morgan Stanley increased its holdings in shares of Tivity Health by 336.2% in the 3rd quarter. Morgan Stanley now owns 3,503,870 shares of the company’s stock worth $80,798,000 after acquiring an additional 2,700,648 shares during the period. Norges Bank acquired a new position in Tivity Health during the 4th quarter valued at about $16,828,000. Patient Capital Management LLC acquired a new position in Tivity Health during the 4th quarter valued at about $9,106,000. JPMorgan Chase & Co. increased its stake in Tivity Health by 107.5% during the 1st quarter. JPMorgan Chase & Co. now owns 557,828 shares of the company’s stock valued at $17,945,000 after buying an additional 288,972 shares during the period. Finally, BlackRock Inc. increased its stake in Tivity Health by 3.1% during the 4th quarter. BlackRock Inc. now owns 7,153,512 shares of the company’s stock valued at $189,140,000 after buying an additional 215,538 shares during the period. Institutional investors own 91.54% of the company’s stock.

About Tivity Health (Get Rating)

Tivity Health, Inc provides fitness and health products and solutions in the United States. The company offers SilverSneakers to members of Medicare Advantage, Medicare Supplement, and group retiree plans; Prime Fitness, a fitness facility access program through commercial health plans, employers, and other sponsoring organizations; virtual fitness experiences, including live instructor-led classes; and WholeHealth living program, a continuum of services related to complementary, alternative, and physical medicine.

Further Reading

Get a free copy of the Zacks research report on Tivity Health (TVTY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.